| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |